Cre-inducible human CD59 mediates rapid cell ablation after intermedilysin administration

Journal of Clinical Investigation

Volumn 126, Issue 6, 2016, Pages 2321-2333

  Feng, Dechun ^a   Dai, Shen ^b,c   Liu, Fengming ^c   Ohtake, Yosuke ^c   Zhou, Zhou ^a   Wang, Hua ^a   Zhang, Yonggang ^c   Kearns, Alison ^c   Peng, Xiao ^c   Zhu, Faliang ^b,c   Hayat, Umar ^c   Li, Man ^a   He, Yong ^a   Xu, Mingjiang ^a   Zhao, Chunling ^c,d   Cheng, Min ^c,d   Zhang, Lining ^b   Wang, Hong ^c   Yang, Xiaofeng ^c   Ju, Cynthia ^e   Bryda, Elizabeth C ^f   Gordon, Jennifer ^c   Khalili, Kamel ^c   Hu, Wenhui ^c   Li, Shuxin ^c   Qin, Xuebin ^c   Gao, Bin ^a   more..

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b SHANDONG UNIVERSITY   (China)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WEIFANG MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF COLORADO   (United States)

^f UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; INTERMEDILYSIN; TOXIN; UNCLASSIFIED DRUG; BACTERIOCIN; CD59 PROTEIN, HUMAN; CRE RECOMBINASE; INTEGRASE; INTERMEDILYSIN PROTEIN, STREPTOCOCCUS INTERMEDIUS;

ABLATION THERAPY; ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DOSE RESPONSE; EPITHELIUM CELL; GENE TARGETING; IMMUNOCOMPETENT CELL; KUPFFER CELL; LIVER CELL; MOUSE; MOUSE MODEL; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATION; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENETICS; HEMOLYSIS; HEPATITIS, ANIMAL; HUMAN; IMMUNOLOGY; LYMPHOCYTE DEPLETION; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD59; ASTROCYTES; BACTERIOCINS; GENE KNOCK-IN TECHNIQUES; HEMOLYSIS; HEPATITIS, ANIMAL; HEPATOCYTES; HUMANS; INTEGRASES; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES;

EID: 84974530576     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI84921     Document Type: Article

References (32)

1. Buch T, et al. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat Methods. 2005;2(6):419-426.
2. Saito M, et al. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat Biotechnol. 2001;19(8):746-750.
3. Minasi LE, Kamogawa Y, Carding S, Bottomly K, Flavell RA. The selective ablation of interleukin 2-producing cells isolated from transgenic mice. J Exp Med. 1993;177(5):1451-1459.
4. Burda JE, Sofroniew MV. Reactive gliosis and the multicellular response to CNS damage and disease. Neuron. 2014;81(2):229-248.
5. Chapman TJ, Georas SN. Adjuvant effect of diphtheria toxin after mucosal administration in both wild type and diphtheria toxin receptor engineered mouse strains. J Immunol Methods. 2013;400-401:122-126.
6. Christiaansen AF, Boggiatto PM, Varga SM. Limitations of Foxp3(+) Treg depletion following viral infection in DEREG mice. J Immunol Methods. 2014;406:58-65.
7. Goldwich A, Steinkasserer A, Gessner A, Amann K. Impairment of podocyte function by diphtheria toxin - a new reversible proteinuria model in mice. Lab Invest. 2012;92(12):1674-1685.
8. Nagamune H, et al. Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess. Infect Immun. 1996;64(8):3093-3100.
9. Giddings KS, Zhao J, Sims PJ, Tweten RK. Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin. Nat Struct Mol Biol. 2004;11(12):1173-1178.
10. Kimberley FC, Sivasankar B, Paul Morgan B. Alternative roles for CD59. Mol Immunol. 2007;44(1-3):73-81.
11. Hu W, et al. Rapid conditional targeted ablation of cells expressing human CD59 in transgenic mice by intermedilysin. Nat Med. 2008;14(1):98-103.
12. Hu W, et al. The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model. Blood. 2010;116(9):1613-1622.
13. Holt MP, Cheng L, Ju C. Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J Leukoc Biol. 2008;84(6):1410-1421.
14. Wang H, Feng D, Park O, Yin S, Gao B. Invariant NKT cell activation induces neutrophil accumulation and hepatitis: opposite regulation by IL-4 and IFN-γ. Hepatology. 2013;58(4):1474-1485.
15. Tiegs G. Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury. Z Gastroenterol. 2007;45(1):63-70.
16. Constantinescu CS, Farooqi N, O'Brien K, Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol. 2011;164(4):1079-1106.
17. Li H, et al. PI3Kγ inhibition alleviates symptoms and increases axon number in experimental autoimmune encephalomyelitis mice. Neuroscience. 2013;253:89-99.
18. Postic C, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β cell-specific gene knock-outs using Cre recombinase. J Biol Chem. 1999;274(1):305-315.
19. + liver progenitors in mouse oval cell injury. Hepatology. 2014;60(1):278-289.
20. Boulter L, et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med. 2012;18(4):572-579.
21. Christiaansen AF, Boggiatto PM, Varga SM. Limitations of Foxp3 Treg depletion following viral infection in DEREG mice. J Immunol Methods. 2014;406:58-65.
22. Mallet VO, et al. Conditional cell ablation by tight control of caspase-3 dimerization in transgenic mice. Nat Biotechnol. 2002;20(12):1234-1239.
23. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol. 2006;6(2):127-135.
24. Lin SL, Castano AP, Nowlin BT, Lupher ML Jr, Duffield JS. Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol. 2009;183(10):6733-6743.
25. Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol. 2010;162(1):1-11.
26. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci. 2011;14(9):1142-1149.
27. Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008;118(10):3420-3430.
28. Kuang SY, et al. Prolonging life in chick forebrain-neuron culture and acquiring spontaneous spiking activity on a microelectrode array. Biotechnol Lett. 2015;37(3):499-509.
29. Witten IB, et al. Recombinase-driver rat lines: tools, techniques, and optogenetic application to dopamine-mediated reinforcement. Neuron. 2011;72(5):721-733.
30. Tweten RK, Hotze EM, Wade KR. The unique molecular choreography of giant pore formation by the cholesterol-dependent cytolysins of gram-positive bacteria. Annu Rev Microbiol. 2015;69:323-340.
31. Kubes P, Mehal WZ. Sterile inflammation in the liver. Gastroenterology. 2012;143(5):1158-1172.
32. Keith BJF, George P. The mouse brain in stereotaxic coordinates. Compact 3rd ed. Amsterdam: Elsevier Academic Press. 2008:plate 29.